Arena Pharmaceuticals, Inc. - Pharmatrack
Research and Markets (http://www. researchandmarkets. com/reports/c10319) has announced the addition of Arena Pharmaceuticals, Inc. - Pharmatrack to their offering
(PRWEB) December 2, 2004
PharmaTrack is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that donÂ’t have adequate analyst coverage, making it a high-in-demand, value added research product. This report profiles Cell Therapeutics Inc.
Each PharmaTrack Profile is packed with crucial data & information and in-depth analysis. The profile elaborates on the companyÂ’s business structure and operations, products and services. It extensively discusses the companyÂ’s financial performance and strategic imperatives from an investorÂ’s perspective and provides a reliable outlook for the future.
Scope of the Report
Provides key company data and analysis to industry players, which is vital to enhance business and competitor intelligence and facilitate decision making
Analyzes the industry and the segment to which the company belongs in a concise manner.
Compares the company vis-Ã -vis its peers in a detailed manner
Discusses also the current industry status and the significant trends that influence the industry
Tracks key initiatives of the company in the recent period across strategic areas of focus
Analyzes the Strengths & Weaknesses of the company (SWOT Analysis)
Analyzes the financial performance of the company for the most recently ended quarter and financial year across businesses, product/service categories and revenue streams
Scope’s comment on the company’s outlook for the forthcoming period – strategic and financial
Supplementary information such the key industry players, overall industry financial and market performance, companyÂ’s board members and senior management team, company and business overview, list of products and services, and stock movements for annual and three-year periods.
Company Brief 1
Key Highlights 1
Stock Data – Last 3 years to date 2 Stock Data – Last 52 weeks 2
Industry Overview 3
Company Overview 10
Business Overview 10 Management Board 11
Shareholding Pattern 12
Insider Ownership 12 Institutional Ownership 12 Public 13
Major Operations 13
Key Partnerships 14
Market Position – Comparison with Industry Peers 15
Strategic Overview 16
SWOT Analysis 16
Strategic Focus 22
Transition to R&D Company 22 Enhancement of Capabilities 23 Restructuring 23
Financial Performance 24
Second Quarter 2004 Performance 24 Full –Year Performance 26
Risk Factors 28
Outlook 29
For more information visit http://www. researchandmarkets. com/reports/c10319 (http://www. researchandmarkets. com/reports/c10319)
Laura Wood
Senior Manager
Research and Markets
Press@researchandmarkets. com
Fax: +353 1 4100 980
###
